Skip to main content

Published locations for ASCO: Ascites may salvage trebananib in recurrent ovarian cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASCO: Ascites may salvage trebananib in recurrent ovarian cancer

User login

  • Reset your password
  • /content/asco-ascites-may-salvage-trebananib-recurrent-ovarian-cancer
  • /obgynnews/article/100238/gynecologic-cancer/asco-ascites-may-salvage-trebananib-recurrent-ovarian
  • /oncologypractice/article/100238/gynecologic-cancer/asco-ascites-may-salvage-trebananib-recurrent
  • /obgyn/article/100238/gynecologic-cancer/asco-ascites-may-salvage-trebananib-recurrent-ovarian-cancer
  • /hematology-oncology/article/100238/gynecologic-cancer/asco-ascites-may-salvage-trebananib-recurrent